Pfizer loses U.K. patent case, opening door to cheap Lyrica copycat drugs

A U.K. High Court judge ruled against Pfizer Inc. in a closely watched patent case involving its blockbuster drug Lyrica, leaving generic-drug makers free to sell cheap copycats of the drug.